14:00 – 18:00

Consensus Development Workshop
GEP-NETs – Asia Pacific Consensus on Management

20:00 - 22:00

Reception and Welcome Dinner

08:25 – 8:30

Opening Remarks

08:30 – 09:00

Hallmarks on Neuroendocrine tumour development

09:00 – 09.20

Symptoms and Investigations

09:20 – 09:40

Radiological Imaging

09:40 – 10:00

Pathological classification

10:00 – 10:10

Case discussion 1: Pitfalls of CGA Testing

10:10 – 10:30

Serum Biomarkers in the Management of NETs

10:30 – 11:00

TEA / COFFEE BREAK

11:00 – 11:20

Molecular Imaging: PET, DOTATATE or both

11:20 – 11:40

Somatostatin Analogues - Anti-tumour Effect

11:40 – 12:00

Case Discussion 2

12:00 – 12:20

Management of Non-secretory Diarrhoea

12:20 – 12:30

Q & A

12:30 – 14:00

Lunch Symposium [Ipsen]

14:20 – 14:30

Should Ki67 decide the chemotherapy regimen in G3 NEC?

14:40 – 15:20

Medical treatment, NOT PRRT should be the 1st line therapy for non-resectable neuroendocrine tumours.
• Medical therapy [15 min]
• PRRT [15 min]

15:20 – 15:40

Surgical Management of GI and HPB NET's - The Tata Memorial Hospital Experience

15:40 – 16:00

Theranostics in NETs - from Imaging to Radioguided Surgery and Therapy

16:00 – 16:20

Immunotherapy; is it a valid alternative for NETs?

16:20 – 16:30

Summary for the Day

16:30 – 17:30

High Tea Symposium [Novartis]

08:30 – 08:50

Classification and Diagnosis

08:50 – 09:10

Carcinoid and Other Paraneoplastic syndromes – an update on management

09:10 – 10:00

Management of Lung NETs
• Surgery [15 min]
• Radiotherapy [15 min]
• Medical therapy [15 min]

10:00 – 10:20

Case discussion 3

10:20 – 10:30

Q & A

10:30 – 11:00

TEA / COFFEE BREAK

11:00 – 11:20

NET G3 - Fact or Fiction?

11:20 – 11:50

Best Abstracts / Oral Presentations

11:50 – 12:00

Q & A

12:00 – 12:30

Presentation of Consensus Development Workshop Outcome: Asia Pacific Consensus on Management of GEP- NETs

12:30 – 12:40

Q & A

12:40 – 12:45

Concluding Remarks

12:45 – 14:00

LUNCH